COMPLEX III AUGMENTS OXIDANTS DAMAGE IN ISCHEMIC AGED HEART
COMPLEX III AUGMENTS OXIDANTS DAMAGE IN ISCHEMIC AGED HEART
批准号:
6783212
负责人:
Edward J Lesnefsky
金额:
$12.76万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2009-07-31
关键词:
age differenceaginganimal old ageantioxidantscardiolipinscytochrome ccytochrome oxidaseelectron transportelectrospray ionization mass spectrometryenzyme complexfree radical oxygengas chromatographyheart electrical activityhemodynamicshigh performance liquid chromatographylaboratory ratlipid metabolismmetabolism disordermiscellaneous oxidoreductasemitochondriamyocardial ischemia /hypoxiamyocardiumnonhuman therapy evaluationoxidative stressperfusionprotein structure functionreperfusion
中文摘要
老年心脏缺血再灌注后心肌损伤加重。与成年对照6个月相比,衰老降低了24个月Fischer 344大鼠心脏的氧化磷酸化速率和电子传递链HI和IV复合物的活性。衰老损伤对心肌线粒体纤维间细胞群具有选择性。
英文摘要
Myocardial injury is increased following ischemia and reperfusion in the aged heart. Aging decreases the rate of oxidative phosphorylation and the activity of complexes HI and IV of the electron transport chain in the 24 mo. Fischer 344 rat heart, compared to 6 mo. adult controls. The aging impairment is selective to the interfibrillar population of cardiac mitochondria 0FM)
that reside among the myofibrils, whereas subsarcolemmal mitochondria (SSM), located beneath the plasma membrane, are unaltered. Complex III contains 11 peptide subunits, including three catalytic centers: cytochrome b, cytochrome c1, and the Rieske iron-sulfur protein (ISP). Aging modifies cytochrome b at the site of substrate oxidation, the Qo site, in IFM. The aging defect in complex III in IFM leads to an increased production of reactive oxygen species (ROS) in the baseline state.
Mitochondrial damage occurs during ischemia in the adult and aged heart. Ischemia damages the ISP of complex III and decreases complex III activity in both populations of mitochondria in adult and aged hearts. In contrast to the adult heart, the aged heart sustains additional oxidative damage to both SSM and IFM during ischemia. Cardiolipin, a key inner mitochondrial membrane phospholipid, is modified only in the aged heart, generating a new molecular species of cardiolipin. Cytochrome c, located in proximity to cardiolipin, is modified, again, only in the aged heart. Cytochrome oxidase activity decreases following ischemia in the aged heart, and, unlike in the adult heart, activity cannot be restored following the addition of exogenous phospholipid. This observation in the aged heart indicates that ischemia led to persistent damage to a peptide subunit of cytochrome oxidase, rather than reversible damage to the inner membrane environment of the complex as in the adult heart. Thus, during ischemia, specific molecular targets in the electron transport chain, including cardiolipin, sustain oxidative damage only in
the aged heart.
Mitochondria are the major source of the ROS generated during myocardial ischemia. Complex III is the major site of ROS production within mitochondria in the adult heart The role of complex III in the oxidative damage sustained by the aged heart during ischemia is unknown. We found that limitation of electron flow into complex III during ischemia achieved by blockade of complex I with rotenone immediately prior to ischemia preserves the rate of oxidative phosphorylation through complexes III and IV in the aged heart.
We propose that during ischemia complex III is a key mechanism of the enhanced oxidative damage observed in the aged heart, We hypothesize that ROS from complex III damage cytochrome oxidase in the aged heart. Oxidative damage during ischemia is accelerated in IFM by the aging defect present at Qo site of complex III. We hypothesize that damage to cytochrome oxidase leads in turn to oxidative modification of cytochrome c and cardiolipin. We hypothesize that following ischemic damage to aged heart mitochondria, ROS production and release is increased, setting the stage for oxidative damage during reperfusion.
Enhanced ROS release from mitochondria, in turn, amplifies cardiac damage and dysfunction during reperfusion that can be decreased by reversibly limiting electron flow into complex III during ischemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metformin Therapy for Ischemic Insult and Reperfusion Injury in Aging
-
批准号:10846164
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2021
-
负责人:Edward J Lesnefsky
-
依托单位:
Metformin Therapy for Ischemic Insult and Reperfusion Injury in Aging
-
批准号:10298194
-
项目类别:
-
资助金额:$24.24万
-
财政年份:2021
-
负责人:Edward J Lesnefsky
-
依托单位:
Metformin Therapy for Ischemic Insult and Reperfusion Injury in Aging
-
批准号:10475290
-
项目类别:
-
资助金额:$19.05万
-
财政年份:2021
-
负责人:Edward J Lesnefsky
-
依托单位:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
-
批准号:8457978
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Edward J Lesnefsky
-
依托单位:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
-
批准号:8795682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Edward J Lesnefsky
-
依托单位:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
-
批准号:8698292
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Edward J Lesnefsky
-
依托单位:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
-
批准号:8333547
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Edward J Lesnefsky
-
依托单位:
Mitochondrial Dysfunction in the Aged Heart: Role of Endoplasmic Reticulum Stress
-
批准号:10513314
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Edward J Lesnefsky
-
依托单位:
Mitochondrial Dysfunction in the Aged Heart: Role of Endoplasmic Reticulum Stress
-
批准号:10254899
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Edward J Lesnefsky
-
依托单位:
Myocardial Infarction in the Aging Heart: Ischemia-Damaged Mitochondria, Reticulum Stress and the Transition to Heart Failure
-
批准号:9239811
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Edward J Lesnefsky
-
依托单位:
ANIMAL / PHYSIOLOGY CORE
-
批准号:6783180
-
项目类别:
-
资助金额:$9.55万
-
财政年份:2004
-
负责人:Edward J Lesnefsky
-
依托单位:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
-
批准号:6359552
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2000
-
负责人:Edward J Lesnefsky
-
依托单位:
CORE--PHYSIOLOGY
-
批准号:6359557
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2000
-
负责人:Edward J Lesnefsky
-
依托单位:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
-
批准号:6218772
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1999
-
负责人:Edward J Lesnefsky
-
依托单位:
CORE--PHYSIOLOGY
-
批准号:6218777
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1999
-
负责人:Edward J Lesnefsky
-
依托单位:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
-
批准号:6098816
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1999
-
负责人:Edward J Lesnefsky
-
依托单位:
CORE--PHYSIOLOGY
-
批准号:6098821
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1999
-
负责人:Edward J Lesnefsky
-
依托单位:
CORE--PHYSIOLOGY
-
批准号:6267779
-
项目类别:
-
资助金额:$9.55万
-
财政年份:1998
-
负责人:Edward J Lesnefsky
-
依托单位:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
-
批准号:6267774
-
项目类别:
-
资助金额:$9.55万
-
财政年份:1998
-
负责人:Edward J Lesnefsky
-
依托单位:
MITOCHONDRIA INCREASE OXIDATIVE INJURY IN AGING HEART
-
批准号:2442192
-
项目类别:
-
资助金额:$8.1万
-
财政年份:1995
-
负责人:Edward J Lesnefsky
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: